Skip to main content
Back
Watch Compare

ProMIS Neurosciences Inc.

Data quality: 83%
PMN
NASDAQ Manufacturing Chemicals
$13.04
▲ $0.44 (3.49%)
Mkt Cap: 108.24 M
Price
$12.07
Mkt Cap
108.24 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Earnings declined -1529.33% over the past year
Negative free cash flow of -28.12 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-1529.33%
FCF Growth (3Y)N/A

Quality

Return on Equity
-902.22%
Below sector avg (-54.47%)
ROIC-710.49%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.76
Interest CoverageN/A

Valuation

PE (TTM)
-2.73
Below sector avg (-1.49)
P/B Ratio11.78
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -2.7 -1.5
P/B 11.8 1.6
ROE % -902.2 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

4 analysts
Strong Buy
Current
$13.04
+162.3%
Target
$34.20
$18.00
$34.73
$49.34
Forecast
Forward EPS -$6.71
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$6.71
-$7.70 – -$5.55
 0.0 3
FY2026 -$6.05
-$6.05 – -$6.05
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$6.71 -$30.05 -348.1%
Q32025 -$9.99 -$8.40 +15.9%
Q22025 -$6.04 -$9.98 -65.3%
Q12025 -$4.30 -$7.35 -71.0%

ETFs Holding This Stock

TBGVX TBGVX
0.77% weight
AVDVX AVDVX
0.00% weight
AVANX AVANX
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -1529.33% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -39.72 M
ROE -902.22% ROA -256.52%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -28.12 M
ROIC -710.49% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.76
Interest Coverage N/A Asset Turnover N/A
Working Capital 9.25 M Tangible Book Value 9.19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.73 Forward P/E N/A
P/B Ratio 11.78 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25.98%
Market Cap 108.24 M Enterprise Value 92.84 M
Per Share
EPS (Diluted TTM) -22.61 Revenue / Share N/A
FCF / Share -3.14 OCF / Share -3.14
EPS CAGR (1Y) -20654.55% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 70.79%
SBC-Adj. FCF -28.89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -39.72 M 2.78 M -13.21 M -18.06 M
EPS (Diluted) -22.61 0.11 -1.07 -2.41
Gross Profit — — — —
Operating Income -40.17 M -16.83 M -14.26 M -23.38 M
EBITDA — — — —
R&D Expenses 33.38 M 10.64 M 7.88 M 16.09 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — 282,064.0 282,064.0
Income Tax — 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 9.18 M 18.91 M 13.62 M 6.92 M
Total Liabilities 10.44 M 2.42 M 9.87 M 8.27 M
Shareholders' Equity -1.26 M 16.49 M 3.75 M -1.35 M
Total Debt — — 0.0 3.91 M
Cash & Equivalents 6.12 M 13.29 M 12.60 M 5.88 M
Current Assets 9.18 M 18.91 M 13.62 M 6.90 M
Current Liabilities 10.41 M 2.22 M 9.35 M 6.41 M